Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: High-protein Oral Nutrition With HMB for Active CD Patients With Sarcopenia [NA]

View source ↗

Summary

A clinical trial assessing whether high-protein oral nutrition with HMB improves muscle strength in active Crohn's disease patients with sarcopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High-protein oral nutrition with HMB (beta-hydroxy beta-methylbutyrate (HMB) in a high-protein oral nutrition formulation)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Handgrip Strength | NA | Status: ENROLLING_BY_INVITATION